Stockreport

Intellia Therapeutics Inc (NTLA) Reports Full-Year 2023 Financial Results and Operational Progress [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF Collaboration Revenue : Decreased to negative $1.9 million in Q4 2023, mainly due to a one-time revenue recognition adjustment. R&D Expenses : Increased to $109.0 mil [Read more]